Opthea Limited operates as a biotechnology company. The Company develops therapies for diabetic macular edema, corneal neovascularization and transplantation, and dry eye disease. Opthea serves patients and healthcare providers in Australia.
CNBC
Yahoo
Access detailed stock analysis from LSEG including analyst price target estimates.
This list tracks the stocks with the most upwards (top gainers) and downwards (top losers) movement in price from the previous day.
Explore
Get Premium